Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Wagner Martin |
Präsentationen bei wissenschaftlichen und nicht-wissenschaftlichen Veranstaltungen
Gulden, L; Katz,L; Fickert, P; Panzitt, K; Wagner, M
Role of the autophagy inhibitor rubicon in a psc mouse model.
IPSCGW Young Investigator Workshop; Dec 16-17. 2024; Birmingham. 2024.
[Oral Communication]
Wagner, M
Gallensäurenmetabolismus
Viszeralmedizinischer Arbeitskreis Essen-Ruhr; APR 17, 2024; Essen, GERMANY. 2024.
[Keynote lecture]
Wagner, M
Herausforderungen und neue Möglichkeiten in der Therapie der Primär biliären Cholangitis (PBC)
Innere Medizin Update Refresher; NOV 26-30, 2024; Vienna, AUSTRIA. 2024.
[Oral Communication]
Wagner, M
Facharztprüfungskurs Hepatologie
Seminar – Innere Medizin mit Fallbeispielen; MAY 16-18, 2024; Vienna, AUSTRIA. 2024.
[Oral Communication]
Wagner, M
Fibroblast growth factors in metabolic health and disease
Symposium Labormedizin Seggauberg bei Graz; MAY 7-8, 2024; Seggauberg bei Graz, AUSTRIA. 2024.
[Oral Communication]
Wagner, M
Aktuelle Therapierichtlinien beim HCC
Kurzfortbildung GE-Besprechung; DEC 19, 2024; Graz, AUSTRIA. 2024.
[Oral Communication]
Wagner, M
HOT TOPICS: Basic Science Leber
6. Klinischer Abend "Hepatobiliäre Chirurgie"; APR 9, 2024; Graz, AUSTRIA. 2024.
[Oral Communication]
Panzitt, K; Jungwirth, E; Madreiter-Sokolowski, C; Madl, T; Trauner, M; Fickert, P; Moore, DD; Thallinger, GG; Marschall, HU; Wagner, M;
FXR signaling is shifted in humans with obesity and adapts hepatic mitochondrial function to increased substrate oxidation
Experimental Hepatology Days, Falk Symposium 233; MAY 18-20, 2023; Zurich, SWITZERLAND. 2023.
[Oral Communication]
Wagner, M
The role of microbiome for protective bile acid profiles
KIMCL Forbildungsveranstaltung; DEC 19,2023; Graz, AUSTRIA. 2023.
[Oral Communication]
Wagner, M
Role of bile acids in the pathogenesis of PSC
International PSC Study Group, Workshop; May 24-26, 2023; Hamburg, GERMANY. 2023.
[Oral Communication]
Xu, R; Moyschewitz, E; Michenthaler, H; Krstic, J; Buerger, M; Amor, M; Kratky, D; Kargl, D; Haemmerle, G; Wagner, M; Prokesch, A
p53 regulation of lipid-associated macrophages upon fasting in liver disease
HISTOLOGIE IN GRAZ
GESTERN – HEUTE – MORGEN
; SEP 11-12, 2023; Graz. 2023.
[Poster]
FullText
Wagner, M
Der Leberrundherd
Gastro Update XVI; APR 2-4, 2022; Leoben, AUSTRIA. 2022.
[Oral Communication]
Wagner, M
The FXR cistrome and transcriptome in obese patients
XXVI International Bile Acid Meeting; JUL 8-9, 2022; Amsterdam, THE NETHERLANDS. 2022.
[Oral Communication]
Wagner, M
Hepatologie
Seminar Innere Medizin; MAY 12-14, 2022; Vienna, AUSTRIA. 2022.
[Oral Communication]
Wagner, M; Jungwirth, E; Panzitt, K; Moore, D; Madl, T; Thallinger, G; Marschall, HU
FXR binding and transcription in the liver is signficantly altered in obese patients with NAFLD
J HEPATOL. 2022; 77: S696-S697.-European Association for the Studies of the Liver - EASL; Jun 22-25, 2022; London, Great Britain.
[Poster]
Web of Science
Leitner, M; Wagner, M; Jahnel, J
Alpha1-Antitrypsin deficiency and liver injury at the Medical University of Graz
WIEN KLIN WOCHENSCHR. 2021; 133(SUPPL 5):180-180.
[Poster]
Web of Science
Meinel, K; Doloresz, S; Deszofi, A; Pohl, S; Strini, T; Greimel, T; Aguiriano Moser, V; Haidl, H; Wagner, M; Schlagenhauf, A; Jahnel, J
Severity of pruritus correlates with human and
muricholic bile acid levels as well as plasmatic autotaxin
concentrations in children and adolescents with chronic cholestatic liver diseases
WCPGHAN 2021, 6th World Congress; JUNE, 2-5, 2021; Vienna, Austria. 2021.
[Poster]
FullText
Munda, P; Aigner, E; Ferlitsch, A; Gschwantler, M; Hofer, H; Maieron, A; Peck-Radosavljevic, M; Stadlbauer-Kollner, V; Wagner, M
Diagnosis and Risk Stratification of non-alcoholic Steatohepatitis (NASH) - a Recommendation from Austrian Hepatologists.
WIEN KLIN WOCHENSCHR. 2020; 132(SUPPL 2):78-78.-ÖGGH Jahrestagung; ÖGGH Wien.
[Oral Communication]
Web of Science
Wagner, M
Cholestasis - Treatment Concepts.
; Vienna. 2020.
[Onlinepräsentation]
Wagner, M
Cholestasis - Differential Diagnosis.
; Vienna. 2020.
[Onlinepräsentation]
Greimel, T; Jahnel, J; Pohl, S; Tischitz, M; Meier-Allard, N; Holasek, S; Zobel, J; Meinel, K; Aguiriano Moser, V; Haidl, H; Panzitt, K; Wagner, M;
Schlagenhauf, A;
Erhöhte Gallensäuren-Konzentrationen führen zu Gerinnungsaktivierung durch Hepatozyten: Ein neuer Pfad in der Pathogenese von cholestatischen Lebererkrankungen im Kindesalter?
Monatsschrift Kinderheilkunde. 2019; 167: s279-312.-Jahrestagung der Österreichischen Gesellschaft für Kinder- und Jugendheilkunde 2019; SEP 18-21, 2019; Klagenfurt, AUSTRIA.
[Oral Communication]
Greimel, T; Jahnel, J; Pohl, S; Tischitz, M; Meier-Allard, N; Holasek, S; Zobel, J; Meinel, K; Aguiriano-Mosser, V; Haidl, H; Panzitt, K; Wagner, M; Schlagenhauf, A
Bile acids trigger coagulation activation potential in hepatocytes:
A contributor to progression of paediatric cholestatic liver diseases?
ESPGHAN 52nd Annual Meeting; JUNE, 5-8, 2019; Glasgow, Scotland. 2019.
[Poster]
FullText
Greimel, T; Jahnel, J; Pohl, S; Tischitz, M; Meinel, K; Aguiriano-Mosser, V; Haidl, H; Panzitt, K; Wagner, M; Schlagenhauf, A
Elevated bile acid levels induce tissue factor activity in
hepatocytes
63rd Annual Meeting of the Society of Thrombosis and Hemostasis Research; FEB 27- MAR 02, 2019; Berlin, GERMANY. 2019.
[Poster]
FullText
Jungwirth, E; Panzitt, K; Marschall, H-U; Wagner, M; Thallinger, GG
A Comprehensive FXR Signaling Atlas Derived from Pooled ChIP-seq Data
Stud Health Technol Inform. 2019;260:105-112.. 2019; -dHealth 2019: eHealth becomes dHealth; MAY 28-29 2019; Vienna, AUSTRIA.
[Oral Communication]
Jungwirth, E; Panzitt, K; Marschall, H-U; Wagner, M; Thallinger, GG,
A Comprehensive FXR Signaling Atlas Derived from Pooled ChIP-seq Data
27th Conference on Inteligent Systems for Molecular Biology and the 18th European Conference on Computational Biology 2019; JUL 21-25, 2019; Basel, SWITZERLAND. 2019.
[Poster]
Krainer, M; Sommer, J; Silbert-Wagner, D; Racedo, S; Panzitt, K; Wagner, M
Does the gut microbiome affect intestinal steroidogenesis?
Z Gastroenterol 2019; 57(05): e137-e138. 2019; -ÖGGH Jahrestagung 2019 ; JUN 13-15, 2019; Innsbruck, AUSTRIA.
[Poster]
Wagner, M
A Comprehensive FXR Signaling Atlas Derived from Pooled ChIP-seq Data
20th Pichlschloss Transporter Meeting; OCT 13-16, 2019; Neumarkt, AUSTRIA. 2019.
[Oral Communication]
Wagner M;
Cholestatic liver diseases
; 2019.
[Oral Communication]
Al-Dury, S; Wahlstrom, A; Katrin, P; Anders, T; Stahlman, M; Olsson, L; Trauner, M; Fickert, P; Moore, D; Backhed, F; Fandriks, L; Wagner, M; Marschall, HU
FXR agonist obeticholic acid increases gallbladder FGF19 in gallstone patients
J HEPATOL. 2018; 68: S449-S449.-International Liver Congress (ILC); APR 11-15, 2018; Paris, FRANCE.
Doi: 10.1016/S0168-8278(18)31140-1
[Oral Communication]
Web of Science
FullText
FullText_MUG
Al-Dury, S; Wahlstrom, A; Panzitt, K; Thorell, A; Stahlman, M; Trauner, MH; Fickert, P; Backhed, F; Fandriks, L; Wagner, M; Marschall, HU
Obeticholic Acid Increases Cholesterol Saturation and FGF19 in Human Gallbladder Bile
HEPATOLOGY. 2018; 68: 159A-159A.-Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD) / Liver Meeting; NOV 09-13, 2018; San Francisco, CA.
[Oral Communication]
Web of Science
Jungwirth, Emilian; Panzitt, Katrin; Wagner Martin; Thallinger, Gerhard G.
Bioinformatic Analysis of FXR related ChIP-seq data
Proceedings of GCB 2018. 2018; -German Conference on Bioinformatics (GCB) 2018; SEP 26-28, 2018; Vienna, AUSTRIA.
[Poster]
FullText
Jungwirth, Emilian; Panzitt, Katrin; Wagner Martin; Thallinger, Gerhard G.
Bioinformatic Analysis of FXR related ChIP-seq data
Austrian Proteomics and Metabolomics Research Symposium APMRS 2018; AUG 29-31, 2018; Vienna, AUSTRIA. 2018.
[Poster]
Jungwirth, Emilian; Panzitt, Katrin; Wagner Martin; Thallinger, Gerhard G.
Bioinformatic Analysis of FXR related ChIP-seq data
Science Connect 2018; NOV 27, 2018; Graz, AUSTRIA. 2018.
[Poster]
Wagner, M;
Clinical Highlights in Liver
UEG Summer School 2018
; May 24-27, 2018 ; Prague, Czech Republic. 2018.
[Oral Communication]
Wagner, M;
Adult treatment options for metabolic liver disease
ESPGHAN Transition Masterclass Paediatric and Adult Gastro-Hepato-Pancreotology; 14th September, 2018; Budapest, Hungary. 2018.
[Oral Communication]
Wagner M;
Nuclear Receptor News
4th Omics Workshop; 22th June, 2018; Graz, Austria. 2018.
[Oral Communication]
Wagner, M; Rainer, F;
Cholestatic liver diseases
UEG Summer School 2018; May 24-27, 2018 ; Prague, Czech Republic. 2018.
[Oral Communication]
Wagner, M; Rainer, F;
Liver elastography & chronic liver disease when to perform a liver biopsy?
European Conference of Young Gastroenterologists; DEC 6.-9., 2018; Zagreb, Croatia. 2018.
[Oral Communication]
Douschan, P; Kovacs, G; Stadlbauer, V; Kniepeiss, D; Krones, E; Durchschein, F; Rainer, F; Spindelboeck, W; Wagner, M; Zollner, G; Avian, A; Fickert, P; Olschewski, A; Olschewski, H; Stauber, RE
Exercise capacity and exercise hemodynamics in the screening for pulmonary vascular disease (PVD) in patients with portal hypertension - results from a prospective cross-sectional study
J HEPATOL. 2017; 66(1):S568-S569.-International Liver Congress / 52nd Annual Meeting of the European-Association-for-the-Study-of-the-Liver; APR 19-23, 2017; Amsterdam, NETHERLANDS.
Doi: 10.1016/S0168-8278(17)31556-8
[Poster]
Web of Science
FullText
FullText_MUG
Horvath, A; Grande, P; Rainer, F; Blesl, A; Meinitzer, A; Leber, B; Schmerböck, B; Komarova, I; Fickert, P; Stiegler, P; Wagner, M; Stadlbauer, V
FGF21 in acute and chronic alcohol consumption
Zeitschrift für Gastroenterologie, Ausgabe 05, Volume 55, Mai 2017. 2017; -Jahrestagung der ÖGGH; JUN 9-10 2017; Linz.
[Poster]
Panzitt, K; Marschall, HU; Trauner, M;Fickert, P; Wagner, M
The autophagy inhibitor Rubicon is a direct target of the bile acid receptor FXR in human liver and is induced in human cholestasis
Keystone. 2017; -Keystone bile acid meeting; March 5-9, 2017; Monterey, USA.
[Poster]
Wagner, M
Role of Xenobiotic Receptors in Regulation of Autophagy
17th Pichlschloss Transporter Weekend; Jul 6-9, 2017; Neumarkt, AUSTRIA. 2017.
[Oral Communication]
Wagner, M
Nuclear Receptors - Bedside Tales
Moore Symposium; AUG 20, 2017; Houston, TX, USA. 2017.
[Oral Communication]
Wagner, M
Cistromics - Establishment and Applications
OMICs Meeting; Nov 6, 2017; Graz, AUSTRIA. 2017.
[Oral Communication]
Grande, P; Horvath, A; Wagner, M; Stadlbauer, V
FGF21 and its connection to alcohol consumption
WIEN KLIN WOCHENSCHR. 2016; 128: S384-S384.
[Poster]
Web of Science
Krones, E; Bork, T; Grahammer, F; Wagner, M; Rosenkranz, AR; Huber, TB; Fickert, P
ACCUMULATION OF LC3 II IN CHOLEMIC NEPHROPATHY IS CAUSED BY BLOCKAGE OF AUTOPHAGIC FLUX
NEPHROL DIAL TRANSPL. 2016; 31: 103-104.-53rd ERA-EDTA Congress; MAY 21-24, 2016; Vienna, AUSTRIA.
[Poster]
Web of Science
Panzitt, K; Marschall, HU; Moore, DD; Trauner, MH; Fickert, P; Wagner, M
The autophagy inhibitor Rubicon is a direct target of the bile acid receptor FXR in human liver and is induced in human cholestasis
HEPATOLOGY. 2016; 63(1 SUPP):159A-159A.-67th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD); NOV 11-15, 2016; Boston, MA.
[Poster]
Web of Science
Panzitt, K; Marschall, HU; Trauner, M; Fickert, P; Wagner,M;
The autophagy inhibitor Rubicon is a direct FXR target in human liver and is induced in human cholestasis
Proceedings of the XXIV International Bile Acid Meeting. 2016; -XXIV International Bile Acid Meeting: Bile Acids in Health and Disease; JUN 17-18, 2016; Düsseldorf, GERMANY.
[Poster]
Panzitt,K; Marschall, HU; Trauner, M; Fickert, P; Wagner, M;
The autophagy inhibitor Rubicon is a direct target of the bile acid receptor FXR in human liver and is induced in human cholestasis
Keystone Symposia Abstract Book "Autophagy: Molecular and physiological mechanisms". 2016; -Autophagy: Molecular and Physiological Mechanisms (V1); JUN 5-9, 2016; Whistler, British Columbia, CANADA.
[Poster]
PK Kump, P Wurm, HP Gröchenig, HH Wenzl, w Petritsch, B Halwachs, M wagner, V. Stadlbauer-Köllner, AJ Eherer, KM Hoffmann, A Deutschmann, G Reicht, L Reiter, P Slawitsch, G Gorkiewicz, C Högenauer
Clinical Response to fecal microbiota Transplantation in chronic active ulcerative colitis depends on the taxonomic composition of the donor microbiota.
United European Gastroenterology Journal; 2016:2 (Supplement 1) . 2016; 2: -UEG week; 15.-19.10.2016; Wien.
[Oral Communication]
Schuller, M; Wagner, M; Panzitt, K
Endogenous phosphatidylcholine generation via the PEMT pathway modulates LRH-1 signaling - Dietary clues for treating NAFLD?
WIEN KLIN WOCHENSCHR. 2016; 128: S383-S384.
[Poster]
Web of Science
Wagner, M;
Cholestatische Lebererkrankungen
Lebertag Graz; FEB 27, 2016; Graz, AUSTRIA. 2016.
[Oral Communication]
Wagner, M;
Nutzen und Schaden von Gallensäuren: Von der Noxe zum Hormon und Biomarker
Viszeralmedizin 2016; SEP 21-24, 2016; Hamburg, GERMANY. 2016.
[Oral Communication]
Wagner, M;
Inhibition of Autophagy by Bile Acids and in Cholestasis
16. Pichlschloss Transport Weekend 2016; JUL 7-10, 2016; Neumarkt, AUSTRIA. 2016.
[Oral Communication]
Panzitt, K; Marschall, H-U; Trauner, M; Fickert, P; Wagner, M;
Effects of Ursodeoxycholic-acid and Rifampicin on autophagy in the liver
UEG Journal. 2015; -UEG Week 2015; 24.10. - 28.10.2015; Barcelona.
[Poster]
Panzitt, K; Marschall, H-U; Trauner, M; Fickert, P; Wagner, M;
Effekte von Ursodeoxycholsäure und Rifampicin auf Autophagie in der Leber
ÖGGH Jahrestagung 2015; 18.6. - 20.6.2015; Salzburg. 2015.
[Poster]
Panzitt, K; Marschall, H-U; Trauner, M; Fickert, P; Wagner, M;
Effects of Ursodeoxycholic-acid and Rifampicin on autophagy in the liver
Hepatology. 2015; -AASLD 2015; 13.11. - 17.11.2015; San Francisco.
[Poster]
Panzitt, K; Marschall, HU; Trauner, M; Fickert, P; Wagner, M
Effects of Ursodeoxycholic-acid and Rifampicin on autophagy in the liver
HEPATOLOGY. . 2015; 62: 538A-538A.-66th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD); NOV 13-17, 2015; San Francisco, CA.
[Oral Communication]
Web of Science
Wagner, M;
Genetic Landscape of FXR in NAFLD in Human - a systems-biological approach
3. Maria Troster Lebertage; 21.5.2015; Graz. 2015.
[Oral Communication]
Wagner, M;
Regulation of Autophagy by
Nuclear Receptors and Bile Acids
Digestive Disease Research Seminar
; 21.10.2015; Vienna. 2015.
[Oral Communication]
Wagner, M;
LRH-1 and the methyl pool
16. Pichlschloss Transport Weekend 2015; 3.7.2015; Neumarkt. 2015.
[Oral Communication]
Douschan, P; Kovacs, G; Stadlbauer-Koellner, V; Spindelboeck, W; Krones, E; Durchschein, F; Zollner, G; Rainer, F; Foris, V; Wagner, M; Fickert, P; Olschewski, H; Stauber, RE
Cardiopulmonary response to exercise in patients with portal hypertension and early stages of liver cirrhosis.
Z Gastroenterol. 2014; 52 - P66: -47. Jahrestagung der Österreichischen Gesellschaft für Gastroenterologie und Hepatologie (ÖGGH); 12. – 14. Juni, 2014; Villach, AUSTRIA.
[Poster]
Zaufel, A; Wagner, M; Krones, E; Fickert, P; Zollner, G
Cholestasis and Bile Acids start the Adrenocortical Function, Salzburg, 25th-27th September, 2014
WIEN KLIN WOCHENSCHR. 2014; 126(17-18):570-571.
[Poster]
Web of Science
Zaufel, A; Wagner, M; Krones, E; Fickert, P; Zollner, G.
Cholestasis and Bile Acids Alter Adrenocortical Function
Proceedings of the XXIII International Bile Acid Meeting. 2014; -Falk Symposum, XXIII International Bile Acid Meeting; OCT 8-9, 2014; Freiburg, GERMANY.
[Poster]
Zaufel, A; Wagner, M; Krones, E; Fickert, P; Zollner, G.
Cholestasis and Bile Acids Alter Adrenocortical Function
Proceedings of the XXIII International Bile Acid Meeting. 2014; -Falk Symposium: XXIII International Bile Acid Meeting; OCT 8-9, 2014; Freiburg, GERMANY.
[Oral Communication]
Mueller, M; Marschall, HU; Claudel, T; Wagner, M; Fickert, P; Lackner, C; Einarsson, C; Thorell, A; Trauner, M
URSODEOXYCHOLIC ACID COUNTERACTS LIPOTOXICITY AND INDUCES UNFOLDED PROTEIN RESPONSE IN MORBIDLY OBESE PATIENTS
J HEPATOL. . 2013; 58: S517-S517.-International Liver Congress / 48th Annual Meeting of the European-Association-for-the-Study-of-the-Liver (EASL); APR 24-28, 2013; Amsterdam, NETHERLANDS.
Doi: 10.1016/S0168-8278(13)61279-9
[Poster]
Web of Science
FullText
FullText_MUG
Marschall, HU; Mueller, M; Claudel, T; Wagner, M; Fickert, P; Zollner, G; Silbert, D; Lackner, K; Thorell, A; Trauner, M
High Levels of Ursodeoxycholic Acid Act as FXR Antagonist
and Deplete Liver Cholesterol due to Increased Bile Acid Synthesis in Morbidly Obese Patients.
classic paper presentation, electronic posters on the EASL member restricted website. 2012; -International Liver Congress(TM) 2012 by EASL; April 18-22, 2012; Barcelona, Spain.
[Poster]
Marschall, HU; Mueller, M; Wagner, M; Fickert, P; Zollner, G; Silbert, D; Lackner, C; Thorell, A; Trauner, M
HIGH LEVELS OF URSODEOXYCHOLIC ACID ACT AS FXR ANTAGONIST AND DEPLETE LIVER CHOLESTEROL DUE TO INCREASED BILE ACID SYNTHESIS IN MORBIDLY OBESE PATIENTS
J HEPATOL. . 2012; 56: S515-S515.-47th Annual Meeting of the European-Association-for-the-Study-of-the-Liver (EASL); APR 18-22, 2012; Barcelona, SPAIN.
Doi: 10.1016/S0168-8278(12)61319-1
[Poster]
Web of Science
FullText
FullText_MUG
Wagner, M; Wooton-Kee, CR; Mamrosh, JL; Lee, JM; Xiao, R; Vareed, SK; Sreekumar, A; Moore, DD
LRH-1 is a key regulator of carbon one metabolism and its loss protects from liver injury in the methionine-choline deficient NASH model
HEPATOLOGY. 2012; 56: 866A-867A.-63rd Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD); NOV 09-13, 2012; Boston, MA.
Web of Science
Mader, JK; Bock, G; Wagner, M; Forrer, F; Lackner, C; Portugaller, RH; Fickert, P; Krejs, GJ; Pieber, TR
Recurrent hypoglycemia in adults - a diagnostic challenge (case report).
WIEN KLIN WOCHENSCHR. 2010; 122(17-18):A7-A7.-ÖGIM; Sep 29-Oct. 1; Salzburg, Austria.
[Poster]
Web of Science
Mader, JM; Bock, G; Wagner, M; Forrer,F; Lackner, C; Portugaller, RH; Fickert, P; Krejs, GJ; Pieber, TR;
Rezidivierende Hypoglykämie im Erwachsenenalter - eine diagnostische Herausforderung (Fallbericht).
Abstractband. 2010; -ÖGIM; 29.9-2.10.2010; Salzburg, Austria.
[Poster]
Stojakovic, T; Claudel, T; Putz-Bankuti, C; Fauler, G; Scharnagl, H; Wagner, M; Sourij, H; Stauber, RE; Winkler, K; Marz, W; Wascher, TC; Trauner, M
LOW-DOSE ATORVASTATIN IMPROVES DYSLIPIDEMIA AND VASCULAR FUNCTION IN PATIENTS WITH PRIMARY BILIARY CIRRHOSIS AFTER ONE YEAR OF TREATMENT.
J HEPATOL. 2010; 52: S431-S432.-45th Annual Meeting of the European Association for the Study of the Liver (EASL); APR 14-18, 2010; Vienna, AUSTRIA.
Doi: 10.1016/S0168-8278(10)61118-X
[Poster]
Web of Science
FullText
FullText_MUG
Stojakovic, T; Claudel, T; Putz-Bankuti, C; Fauler, G; Scharnagl, H; Wagner, M; Sourij, H; Stauber, RE; Winkler, K; März, W; Wascher, TC; Trauner, M
Low-dose atorvastatin improves dyslipidemia and vascular function in patients with primary biliary cirrhosis after one year of treatment.
3rd Annual Congress of the Austrian Society for Laboratory Medicine and Clinical Chemistry; OCT 27-30, 2010; Salzburg, AUSTRIA. 2010.
[Oral Communication]
Klein, K; Eloranta, JJ; Wagner, M; Trauner, M; Kullak-Ublick, GA
Regulation of human concentrative nucleoside transporter-1 gene expression
NAUNYN-SCHMIED ARCH PHARMACOL. 2009; 379: 490-
[Oral Communication]
Web of Science
Marschall, HU; Wagner, M; Zollner, G; Fickert, P; Lundasen, T; Gustafsson, U; Sahlin, S; Trauner, M
STIMULATION OF HEPATOBILIARY DETOXIFICATION AND TRANSPORT SYSTEMS IN HUMAN LIVER BY COMBINED TREATMENT WITH RIFAMPICIN AND URSODEOXYCHOLIC ACID
J HEPATOL. 2009; 50: 675-Vienna, Austria.
Doi: 10.1016/S0168-8278(09)60677-2
[Poster]
Web of Science
FullText
FullText_MUG
Marshall, H; Wagner, M; Zoller, G; Fickert, P; Gustafsson, U; Sahlin, S; Trauner, M
Combined treatment with rifamppicin and ursodeoxycholic acid in humans stimulates bile acid synthesis, detoxification and bilirubin elimination.
Gut2009; 58(SII):A49-A49.-GASTRO 2009 UEGW/WCOG; NOV 21-25,2009; London, GREAT BRITAIN.
[Oral Communication]
Stojakovic, T; Claudel, T; Putz-Bankuti, C; Fauler, G; Scharnagl, H; Wagner, M; Sourij, H; Stauber, RE; Winkler, K; März, W; Wascher, TC; Trauner, M
Low-dose atorvastatin improves dyslipidemia and vascular function in patients with primary biliary cirrhosis after one year of treatment.
39. Jahrestagung des Arbeitskreises "Klinischer Lipidstoffwechsel"; NOV 26-28, 2009; Maikammer, GERMANY. 2009.
[Oral Communication]
Stojakovic, T; Claudel, T; Putz-Bankuti, C; Fauler, G; Scharnagl, H; Wagner, M; Sourij, H; Stauber, RE; Winkler, K; März, W; Wascher, TC; Trauner, M
Improvement of lipoprotein pattern and vascular function in patients with primary biliary cirrhosis after long-term treatment with atorvastatin.
1st Styrian Conference on Lipid Mass Spectrometry; OCT 21-22, 2009; Graz, AUSTRIA. 2009.
[Poster]
Stojakovic, T; Putz-Bankuti, C; Fauler, G; Scharnagl, M; Wagner, M; Sourij, H; Stauber, RE; Marz, W; Wascher, TC; Trauner, M
Low-dose atorvastatin improves dyslipidemia and vascular function in patients with primary biliary cirrhosis after one year of treatment
WIEN KLIN WOCHENSCHR. 2009; 121(15-16):A26-A26.-40.Jahrestagung der Österreichischen Gesellschaft für Innere Medizin (ÖGIM); SEP 17-19, 2009; Vienna, AUSTRIA.
[Poster]
Web of Science
Stojakovic, T; Putz-Bankuti, C; Fauler, G; Scharnagl, H; Wagner, M; Sourij, H; Stauber, RE; März, W; Wascher, TC; Trauner, M
Improvement of dyslipidemia and vascular function in patients with primary biliary cirrhosis after long-term treatment with atorvastatin.
Clin Chem Lab Med. 2008; 46(9):A181-A181.-5. Jahrestagung der Deutschen Vereinten Gesellschaft für Klinische Chemie und Laboratoriumsmedizin (DGKL); SEP 21-24, 2008; Mannheim, GERMANY.
[Poster]
Stojakovic, T; Putz-Bankuti, C; Scharnagl, H; Wagner, M; Sourij, H; März, W; Wascher, TC; Trauner, M
Long-term treatment with atorvastatin improves dyslipidemia and vascular function in patients with primary biliary cirrhosis.
15. Jahrestagung der Österreichischen Atherosklerosegesellschaft - Austrian Atherosclerosis Society (AAS); APR 18-19, 2008; St. Gilgen, AUSTRIA. 2008.
[Poster]
Stojakovic, T; Putz-Bankuti, C; Scharnagl, H; Wagner, M; Sourij, H; März, W; Wascher, TC; Trauner, M
Long-term treatment with atorvastatin improves dyslipidemia and vascular function in patients with primary biliary cirrhosis.
Z Gastroenterol. 2008; 45: 1-1.-41. Jahrestagung und 19. Fortbildungskurs der Österreichischen Gesellschaft für Gastroenterologie und Hepatologie (ÖGGH); MAI 29-31, 2008; Millstatt, AUSTRIA.
[Oral Communication]
Stojakovic, T; Putz-Bankuti, C; Scharnagl, H; Wagner, M; Wascher, TC; März, W; Trauner, M.
Improvement of dyslipidemia and vascular function in patients with cholestatic liver disease after long-term treatment with atorvastatin
Hämostaseologie. 2008; 28(1-2):A62-A62.-52. Jahrestagung der Gesellschaft für Thrombose- und Hämostaseforschung e. V. (GTH); FEB 20-23, 2008; Wiesbaden, Germany.
[Poster]
Stojakovic, T; Putz-Bankuti, C; Wagner, M; Scharnagl, H; Wascher, TC; Marz, W; Trauner, M
Long-term treatment with atorvastatin in patients with cholestatic liver disease.
ATHEROSCLER SUPPL 2008; 9(1):197-197.-77th Congress of the European Atherosclerosis Society; APR 26-29, 2008; Istanbul, TURKEY.
[Poster]
Jahnel, J; Wagner, M; Langner, C; Hoegenauer, C; Fickert, P; Silbert, D; Gumhold, J; Fuchsbichler, A; Denk, H; Trauner, M
Impact of colitis on bile secretion and hepatobiliary transporter expression in mice possible implications for pathogenesis of sclerosing cholangitis
J HEPATOL. 2007; 46: S122-S122.
Doi: 10.1016/S0168-8278(07)61907-2
[Poster]
Web of Science
FullText
FullText_MUG
Wagner, M; Moustafa, T; Fickert, P; Zollner, G; Gumhold, J; Silbert, D; Fuchsbichler, A; Zatloukal, K; Denk, H; Trauner, M
Absence of FXR protects mice from bile-infarcts in biliary obstruction by reduction of bile acid-independent bile flow: Implications for targeting FXR in treatment of cholestasis?
J HEPATOL. 2007; 46: S5-S5.-42th Annual Meeting, European Association for the Study of the Liver; April, 11-15, 2007; Barcelona, Spain.
Doi: 10.1016/S0168-8278(07)61603-1
[Oral Communication]
Web of Science
FullText
FullText_MUG
Zollner, G; Caligiuri, A; Fickert, P; Wagner, M; Silbert, D; Pinzani, M; Trauner, M
Expression of bile acid transport and detoxification systems and their regulatory nuclear receptors in human hepatic stellate cells
J HEPATOL. 2007; 46: S135-S135.-42th Annual Meeting, European Association for the Study of the Liver ; April 11-15, 2007; Barcelona, Spain.
Doi: 10.1016/S0168-8278(07)61944-8
[Poster]
Web of Science
FullText
FullText_MUG
Moustafa, T; Fickert, P; Prokesch, A; Wagner, M; Fuchsbichler, A; Silbert, D; Gumhold, J; Denk, H; Trajanoski, Z; Trauner, M
Common bile-duct-ligation of FXR knockout mice results in severe hepatic steatosis due to enhancement in lipogenic gene expression
J HEPATOL. 44: S28-S28.-41st Annual Meeting of the European-Association-for-the-Study-of-the-Liver; APR 26-30, 2006; Vienna, AUSTRIA.
Doi: 10.1016/S0168-8278(06)80063-2
[Poster]
Web of Science
FullText
FullText_MUG
Wagner, M
Effects of UDCA on intestinal bile acid signalling in cholestasis.
7. Pichlschloß Transport Wochenende; JULI 6-9,; Neumarkt/ Steiermark. 2006.
[Oral Communication]
Wagner, M; Fickert, P; Zollner, G; Trauner, M
24-nor-ursodeoxycholic acid ameliorates sclerosing cholangitis in Mdr2 knockout mice.
4th Central European Gastroenterology Meeting; Juni 29 - Juli 2; Visegrad, Ungarn. 2006.
[Oral Communication]
Wagner, M; Halilbasic, E; Marschall, HU; Zollner, G; Fickert, P; Langner, C; Zatloukal, K; Denk, H; Trauner, M
CAR and PXR agonists stimulate hepatic bile acid and bilirubin detoxification and elimination pathways in mice.
Forum Forschung, Sanofi-Aventis Preisverleihung; NOV 8; Graz. 2006.
[Oral Communication]
Zollner, G; Wagner, M; Moustafa, T; Fickert, P; Silbert, D; Gumhold, J; Helmut, D; Marschall, HU; Trauner, M
Role of nuclear bile acid receptor FXR in regulation of bile acid detoxification and organic solute transporter (OST-alpha/beta) expression in bile acid-fed mice
J HEPATOL. 44: S124-S124.-41st Annual Meeting of the European-Association-for-the-Study-of-the-Liver; APR 26-30, 2006; Vienna, AUSTRIA.
Doi: 10.1016/S0168-8278(06)80322-3
[Poster]
Web of Science
FullText
FullText_MUG
Fickert, P; Fuchsbichler, A; Wagner, M; Zollner, G; Krause, R; Zatloukal, K; Marschall, HU; Jaeschke, H; Denk, H; Trauner, M
Lithocholic acid feeding induces biliary obstruction and destructive cholangitis in mice
J HEPATOL. 2005; 42: 113-113.-40th Annual Meeting of the European-Association-for-the-Study-of-the-Liver; APR 13-17, 2005; Paris, FRANCE.
Web of Science
Fickert, P; Wagner, M; Marshall, HU; Fuchsbichler, A; Zollner, G; Zatloukal, K; Liu, J; Waalkes, MP; Cover, C; Denk, H; Hofmann, AF; Jaeschke, H; Trauner, M
24-norursodeoxycholic acid as novel therapeutic approach to sclerosing cholangitis in Mdr2 (ABCB4) knockout mice
HEPATOLOGY. 2005; 42: -56th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases; NOV 11-15, 2005; San Francisco, CA.
Web of Science
Geier, A; Zollner, G; Dietrich, CG; Wagner, M; Fickert, P; Denk, H; van Rooijen, N; Matern, S; Gartung, C; Trauner, M
Cytokine-independent repression of rodent Ntcp in obstructive cholestasis
J HEPATOL. 2005; 42: 114-114.-40th Annual Meeting of the European-Association-for-the-Study-of-the-Liver; APR 13-17, 2005; Paris, FRANCE.
Web of Science
Marschall, HU; Wagner, M; Zollner, G; Fickert, P; Gumhold, J; Silbert, D; Diczfalusy, U; Benthin, L; Grundstrom, R; Gustafsson, U; Sahlin, S; Einarsson, C; Trauner, M
Complementary stimulation of hepatobiliary transport and detoxification systems by rifampicin and ursodeoxycholic acid in human liver
GASTROENTEROLOGY. 2005; 128: A755-A755.
Web of Science
Stojakovic, T; Putz-Bankuti, C; Fauler, G; Scharnagl, H; Wagner, M; Stadlbauer, V; Gurakuqi, G; Stauber, RE; März, W; Trauner, M
Atorvastatin in patients with primary biliary cirrhosis and an incomplete response to ursodeoxycholic acid.
35. Jahrestagung des Arbeitskreises "Klinischer Lipidstoffwechsel"; NOV 25-27, 2005; Maikammer, Deutschland. 2005.
[Oral Communication]
Wagner, M; Zollner, G; Fickert, P; Gumhold, J; Silbert, D; Fuchsbichler, A; Gujral, J; Zatloukal, K; Jaeschke, H; Deck, H; Trauner, M
Role of inflammation for hepatobiliary transporter expression in ICAM-/- and lpr mice after common bile duct ligation
GASTROENTEROLOGY. 2005; 128: A89-A89.
Web of Science
Wagner, M; Zollner, G; Fickert, P; Gumhold, J; Silbert, D; Fuchsbichler, A; Gujral, JS; Zatloukal, K; Denk, H; Jaeschke, H; Trauner, M
Alterations of hepatobiliary transporter expression in response to common bile duct ligation in mice are independent of ICAM-1 and FAS-receptor expression
J HEPATOL. 2005; 42: 115-115.-40th Annual Meeting of the European-Association-for-the-Study-of-the-Liver; APR 13-17, 2005; Paris, FRANCE.
Web of Science
Zollner, G; Wagner, M; Fickert, P; Gumhold, J; Silbert, D; Marschall, HU; Denk, H; Trauner, M
Expression of bile acid synthesis and detoxification enzymes and the alternative bile acid efflux pump MRP4 in patients with primary biliary cirrhosis
GASTROENTEROLOGY. 2005; 128: A691-A691.
Web of Science
Zollner, G; Wagner, M; Fickert, P; Gumhold, J; Silbert, D; Marschall, HU; Denk, H; Trauner, M
Expression of key bile acid detoxification enzymes and the alternative bile acid export pump MRP4 in primary biliary cirrhosis
J HEPATOL. 2005; 42: 240-240.-40th Annual Meeting of the European-Association-for-the-Study-of-the-Liver; APR 13-17, 2005; Paris, FRANCE.
Web of Science
Fickert, P; Fuchsbichler, A; Wagner, M; Zollner, G; Kaser, A; Tilg, H; Krause, R; Langner, C; Zatloukal, K; Marschall, HU; Denk, H; Trauner, M
Bile acids regurgitation from leaky bile ducts causes sclerosing cholangitis in Mdr2 knockout mice
GASTROENTEROLOGY. 2004; 126: A663-A663.
Web of Science
Fickert, P; Fuchsbichler, A; Wagner, M; Zollner, G; Kaser, A; Tilg, H; Krause, R; Langner, C; Zatloukal, K; Marschall, HU; Denk, H; Trauner, M
Biliary leakage of fluorescent bile acids in MDR2 knockout mice: Evidence for a critical role of bile duct leakage in the pathogenesis of sclerosing cholangitis
J HEPATOL. 2004; 40: 91-91.-39th Annual Meeting of the European-Association-for-the-Study-of-the-Liver; APR 14-18, 2004; Berlin, GERMANY.
Doi: 10.1016/S0168-8278(04)90295-4
Web of Science
FullText
FullText_MUG
Fickert, P; Trauner, M; Fuchsbichler, A; Zollner, G; Wagner, M; Marschall, HU; Zartloukal, K; Denk, H; Zsengeller, Z; Szabo, C
Oncosis represents the main type of cell death in mouse models of cholestasis: evidence for a critical role of poly(ADP-ribose) polymerase (PARP) activation in bile acid-induced hepatocytes death
FASEB J. 2004; 18: A558-A558.-Experimental Biology 2004 Meeting; APR 17-21, 2004; Washington, DC.
Web of Science
Marschall, HU; Wagner, M; Zollner, G; Fickert, P; Gumhold, J; Silbert, D; Diczfalusy, U; Benthin, L; Grundstrom, R; Sahlin, S; Einarsson, C; Trauner, M
Comprehensive study of the effects of rifampicin and ursodeoxycholic acid on genes and proteins involved in regulation, transport and detoxification of biliary compounds in gallstone patients
GASTROENTEROLOGY. 2004; 126: A746-A746.
Web of Science
Marschall, HU; Wagner, M; Zollner, G; Fickert, P; Gumholdt, J; Silbert, D; Diczfalusy, U; Benthin, L; Grundstrom, R; Sahlin, S; Einarsson, C; Trauner, M
Comprehensive study of the effects of rifampicin and ursodeoxycholic acid on genes and proteins involved in regulation, transport and detoxification of biliary compounds in gallstone patients
J HEPATOL. 2004; 40: 93-93.-39th Annual Meeting of the European-Association-for-the-Study-of-the-Liver; APR 14-18, 2004; Berlin, GERMANY.
Doi: 10.1016/S0168-8278(04)90303-0
Web of Science
FullText
FullText_MUG
Wagner, M; Fickert, P; Marschall, HU; Zollner, G; Silbert, D; Fuchsbichler, A; Gumhold, J; Schuetz, JD; Gonzalez, FJ; Zatloukal, K; Denk, H; Trauner, M
Alternative exretory routes for accumulating bile acids via adaptive renal ABC transporter expression in common bile duct-ligated (CBDL) mice
GASTROENTEROLOGY. 2004; 126: A129-A130.
Web of Science
Wagner, M; Fickert, P; Zollner, G; Fuchsbichler, A; Gumhold, J; Silbert, D; Zatloukal, K; Gu, GL; Marschall, HU; Denk, H; Trauner, M
Role of adaptive hepatobiliary transporter expression and regulation of bile acid synthetic enzymes in MDR2-/- mice: A model for chronic cholestatic liver disease due to sclerosing cholangitis
J HEPATOL. 2004; 40: 163-163.-39th Annual Meeting of the European-Association-for-the-Study-of-the-Liver; APR 14-18, 2004; Berlin, GERMANY.
Doi: 10.1016/S0168-8278(04)90557-0
Web of Science
FullText
FullText_MUG
Wagner, M; Fickert, P; Zollner, G; Silbert, D; Fuchsbichler, A; Gumhold, J; Schuetz, JD; Gonzalez, FJ; Zatloukal, K; Marschall, HU; Denk, H; Trauner, M
Adaptive renal ABC transporter expression in common bile duct-ligated mice
J HEPATOL. 2004; 40: 26-26.-39th Annual Meeting of the European-Association-for-the-Study-of-the-Liver; APR 14-18, 2004; Berlin, GERMANY.
Doi: 10.1016/S0168-8278(04)90073-6
Web of Science
FullText
FullText_MUG
Wagner, M; Fickert, P; Zollner, G; Silbert, D; Gumhold, J; Fuchsbichler, A; Zatloukal, K; Marschall, HU; Denk, H; Trauner, M
Hepatic and renal ABC transporter expression in mice depends on gender and changes in pregnancy
GASTROENTEROLOGY. 2004; 126: A130-A130.
Web of Science
Wagner, M; Fickert, P; Zollner, G; Silbert, D; Gumhold, J; Fuchsbichler, A; Zatloukal, K; Marschall, HU; Denk, H; Trauner, M
Gender and pregnancy affect hepatic and renal ABC transporter expression in mice
J HEPATOL. 2004; 40: 94-94.-39th Annual Meeting of the European-Association-for-the-Study-of-the-Liver; APR 14-18, 2004; Berlin, GERMANY.
Doi: 10.1016/S0168-8278(04)90307-8
Web of Science
FullText
FullText_MUG
Wagner, M; Halilbasic, E; Fickert, P; Zollner, G; Fuchsbichler, A; Gumhold, J; Silbert, D; Zatloukal, K; Denk, H; Trauner, M
Nuclear receptor (PXR, CAR) agonists induce adaptive hepatic transporter and enzyme expression in mouse liver
J HEPATOL. 2004; 40: 25-25.-39th Annual Meeting of the European-Association-for-the-Study-of-the-Liver; APR 14-18, 2004; Berlin, GERMANY.
Doi: 10.1016/S0168-8278(04)90069-4
Web of Science
FullText
FullText_MUG
Wagner, M; Halilbasic, E; Zollner, G; Fickert, P; Gumhold, J; Silbert, D; Fuchsbichler, A; Zatloukal, K; Denk, H; Trauner, M
Xenobiotic nuclear receptor (PXR, CAR) agonists coordinately stimulate a spectrum of detoxification enzymes and transport systems involved in the adaptive response to cholestasis in vivo.
HEPATOLOGY. 2004; 40: 489A-489A.-55th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD); OCT 29-NOV 02, 2004; Boston, MA.
Web of Science
Zollner, G; Halilbasic, E; Wagner, M; Fickert, P; Silbert, D; Gumhold, J; Fuchsbichler, A; Zatloukal, K; Denk, H; Trauner, M
Cholic acid (CA) and ursodeoxycholic acid (UDCA) exert different effects on hepatic and renal expression of Mrp4 and Mrp6, two novel ABC transporters
GASTROENTEROLOGY. 2004; 126: A16-A16.
Web of Science
Zollner, G; Halilbasic, E; Wagner, M; Fickert, P; Silbert, D; Gumhold, J; Fuchsbichler, A; Zatloukal, K; Denk, H; Trauner, M
Differential effects of ursodeoxycholic acid (UDCA) and cholic acid (CA) on hepatic and renal expression of MRP4 and MRP6, two novel abc transporters, in mice
J HEPATOL. 2004; 40: 25-25.
Doi: 10.1016/S0168-8278(04)90070-0
Web of Science
FullText
FullText_MUG
Zollner, G; Wagner, M; Fickert, P; Fuchsbichler, A; Gumhold, J; Silbert, D; Zatloukal, K; Guo, GL; Marschall, HU; Denk, H; Trauner, M
Mdr2(-/-) mice with sclerosing cholangitis: A model of chronic cholestasis to study the role of the adaptive response of hepatobiliary transport systems and bile acid synthetic enzymes
GASTROENTEROLOGY. 2004; 126: A751-A751.
Web of Science
Fickert, P; Trauner, M; Fuchsbichler, A; Zollner, G; Wagner, M; Zenz, R; Zsengeller, Z; Szabo, C; Denk, H
Inhibition of poly(ADP-ribose) polymerase (PARP) protects mice from cholestatic liver injury.
HEPATOLOGY 2003 38: 576A-576A.
Web of Science
Wagner, M; Fickert, P; Fuchsbichler, A; Silbert, D; Gumhold, J; Zollner, G; Zatloukal, K; Marschall, HU; Schuetz, JD; Gonzalez, FJ; Denk, H; Trauner, M
Hepatic and renal ABC transporter expression as critical determinants of ursodeoxycholic acid-induced bile infarcts in bile duct-ligated mice.
HEPATOLOGY 2003 38: 688A-689A.
Web of Science
Wagner, M; Fickert, P; Zollner, G; Fuchsbichler, A; Silbert, D; Marschall, HU; Gonzalez, FJ; Zatloukal, K; Denk, H; Trauner, M
The role of the bile acid receptor FXR in determining ATP-binding cassette (ABC) transporter expression and liver injury in common bile duct ligated (CBDL) mice
J HEPATOL 2003 38: 190-190.
Doi: 10.1016/S0168-8278(03)80031-4
Web of Science
FullText
FullText_MUG
Wagner, M; Fickert, P; Zollner, G; Fuchsbichler, A; Silbert, D; Tsybrovskyy, O; Gonzalez, FJ; Zatloukal, K; Marschall, HU; Denk, H; Trauner, M
Role of nuclear bile acid receptor, FXR, in determining ATP-binding cassette (ABC) transporter expression and cholestatic liver injury in common bile duct-ligated mice
GASTROENTEROLOGY 2003 124: A697-A698.
Doi: 10.1016/S0016-5085(03)83527-8
Web of Science
FullText
FullText_MUG
Zollner, G; Fickert, P; Silbert, D; Fuchsbichler, A; Wagner, M; Guo, G; Gonzalez, FJ; Zatloukal, K; Denk, H; Trauner, M
Role of nuclear bile salt receptors Fxr and Pxr in mediating adaptive hepatobiliary transporter response to cholic acid (CA) in mouse liver
GASTROENTEROLOGY 2003 124: A59-A59.
Doi: 10.1016/S0016-5085(03)80292-5
Web of Science
FullText
FullText_MUG
Zollner, G; Fickert, P; Silbert, D; Fuchsbichler, A; Wagner, M; Zatloukal, K; Denk, H; Trauner, M
Role of short heterodimer partner (SHP) -dependent and -independent pathways for regulation of Na+/taurocholate cotransporter (NTCP) expression in cholestatic mouse models.
J HEPATOL. 2003; 38(2):9-10.-38th Annual Meeting of the European-Association-for-the-Study-of-the-Liver; MAR 29-APR 01, 2003; ISTANBUL, TURKEY.
Doi: 10.1016/S0168-8278(03)80442-7
Web of Science
PubMed
FullText
FullText_MUG
Zollner, G; Fickert, P; Silbert, D; Fuchsbichler, A; Wagner, M; Zatloukal, K; Denk, H; Trauner, M
Regulation of the Na+/taurocholate cotransporter Ntcp via short heterodimer partner (SHP)-dependent or SHP-independent mechanims depends on the type of cholestatic injury
GASTROENTEROLOGY 2003 124: A730-A730.
Doi: 10.1016/S0016-5085(03)83688-0
Web of Science
FullText
FullText_MUG
Zollner, G; Fickert, P; Wagner, M; Fuchsbichler, A; Silbert, D; Gumhold, J; Zatloukal, K; Denk, H; Trauner, M
Induction of intestinal multidrug resistance-associated proteins 2 and 3 (Mrp2, Mrp3) by cholic acid (CA) and ursodeoxycholic acid (UDCA) in mice.
HEPATOLOGY 2003 38: 689A-689A.
Web of Science